Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanda Baer-Dubowska

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Acta Poloniae Pharmaceutica|March 16, 2007
Cancer chemopreventive agents-drugs for the 21st century?Wanda Baer-Dubowska
Przeglad Lekarski|February 10, 2007
[Tobacco smoking related DNA and protein adducts and risk of degenerative diseases]Wanda Baer-Dubowska
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2013
Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humansWanda Baer-Dubowska, Hanna Szaefer
Postepy Higieny I Medycyny Doswiadczalnej (Online)|May 26, 2010
[Estrogen intracrinology: therapy and chemoprevention of breast cancer]Barbara Licznerska, Wanda Baer-Dubowska
Advances in Experimental Medicine and Biology|September 28, 2016
Indole-3-Carbinol and Its Role in Chronic DiseasesBarbara Licznerska, Wanda Baer-Dubowska
Postepy Biochemii|November 1, 2007
[RasGRP proteins--Ras-activating factors]Mateusz Szamałek, Wanda Baer-Dubowska
Current Pharmaceutical Biotechnology|September 10, 2011
Searching for artemisinin production improvement in plants and microorganismsKatarzyna Barbacka, Wanda Baer-Dubowska
Postepy Biochemii|December 31, 2005
[Epigenome and cancer: new possibilities of cancer prevention and therapy?]Jarosław Paluszczak, Wanda Baer-Dubowska
Postepy Biochemii|July 17, 2024
From single DNA adducts measurement to DNA adductomics in molecular epidemiology of cancerWanda Baer-Dubowska, Hanna Szaefer
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2020
What might the presence of 'orphan' CYP450 isoforms in breast epithelial cells mean for the future of targeted therapeutics?Barbara Licznerska, Wanda Baer-Dubowska
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Acta Poloniae Pharmaceutica|March 16, 2007
Cancer chemopreventive agents-drugs for the 21st century?Wanda Baer-Dubowska
Przeglad Lekarski|February 10, 2007
[Tobacco smoking related DNA and protein adducts and risk of degenerative diseases]Wanda Baer-Dubowska
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2013
Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humansWanda Baer-Dubowska, Hanna Szaefer
Postepy Higieny I Medycyny Doswiadczalnej (Online)|May 26, 2010
[Estrogen intracrinology: therapy and chemoprevention of breast cancer]Barbara Licznerska, Wanda Baer-Dubowska
Advances in Experimental Medicine and Biology|September 28, 2016
Indole-3-Carbinol and Its Role in Chronic DiseasesBarbara Licznerska, Wanda Baer-Dubowska
Postepy Biochemii|November 1, 2007
[RasGRP proteins--Ras-activating factors]Mateusz Szamałek, Wanda Baer-Dubowska
Current Pharmaceutical Biotechnology|September 10, 2011
Searching for artemisinin production improvement in plants and microorganismsKatarzyna Barbacka, Wanda Baer-Dubowska
Postepy Biochemii|December 31, 2005
[Epigenome and cancer: new possibilities of cancer prevention and therapy?]Jarosław Paluszczak, Wanda Baer-Dubowska
Postepy Biochemii|July 17, 2024
From single DNA adducts measurement to DNA adductomics in molecular epidemiology of cancerWanda Baer-Dubowska, Hanna Szaefer
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2020
What might the presence of 'orphan' CYP450 isoforms in breast epithelial cells mean for the future of targeted therapeutics?Barbara Licznerska, Wanda Baer-Dubowska
Pageof 10